Literature DB >> 23026637

Fusion protein linkers: property, design and functionality.

Xiaoying Chen1, Jennica L Zaro, Wei-Chiang Shen.   

Abstract

As an indispensable component of recombinant fusion proteins, linkers have shown increasing importance in the construction of stable, bioactive fusion proteins. This review covers the current knowledge of fusion protein linkers and summarizes examples for their design and application. The general properties of linkers derived from naturally-occurring multi-domain proteins can be considered as the foundation in linker design. Empirical linkers designed by researchers are generally classified into 3 categories according to their structures: flexible linkers, rigid linkers, and in vivo cleavable linkers. Besides the basic role in linking the functional domains together (as in flexible and rigid linkers) or releasing the free functional domain in vivo (as in in vivo cleavable linkers), linkers may offer many other advantages for the production of fusion proteins, such as improving biological activity, increasing expression yield, and achieving desirable pharmacokinetic profiles.
Copyright © 2012 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Bifunctional recombinant proteins; EBFP; EGFP; FIX; FRET; G-CSF; HSA; IFN; LAP; MMP; PD; PDB; PK; Pharmacodynamics; Pharmacokinetics; Protein Data Bank; Spacer; TGN; Tf; V(H); V(L); aa; amino acid; antibody heavy chain variable region; antibody light-chain variable regions; coagulation factor IX; enhanced blue fluorescent protein; enhanced green fluorescent protein; fluorescent resonance energy transfer; granulocyte colony-stimulating factor; hGH; human growth hormone; human serum albumin; interferon; latency associated peptide; matrix metalloproteinase; pharmacodynamic; pharmacokinetic; scFv; single-chain variable fragment; trans-golgi network; transferrin

Mesh:

Substances:

Year:  2012        PMID: 23026637      PMCID: PMC3726540          DOI: 10.1016/j.addr.2012.09.039

Source DB:  PubMed          Journal:  Adv Drug Deliv Rev        ISSN: 0169-409X            Impact factor:   15.470


  84 in total

Review 1.  Single-chain antibodies as diagnostic tools and therapeutic agents.

Authors:  Christoph E Hagemeyer; Constantin von Zur Muhlen; Dominik von Elverfeldt; Karlheinz Peter
Journal:  Thromb Haemost       Date:  2009-06       Impact factor: 5.249

Review 2.  Fusion-proteins as biopharmaceuticals--applications and challenges.

Authors:  Stefan R Schmidt
Journal:  Curr Opin Drug Discov Devel       Date:  2009-03

3.  Transferrin fusion technology: a novel approach to prolonging biological half-life of insulinotropic peptides.

Authors:  Byung-Joon Kim; Jie Zhou; Bronwen Martin; Olga D Carlson; Stuart Maudsley; Nigel H Greig; Mark P Mattson; Ellen E Ladenheim; Jay Wustner; Andrew Turner; Homayoun Sadeghi; Josephine M Egan
Journal:  J Pharmacol Exp Ther       Date:  2010-05-24       Impact factor: 4.030

Review 4.  The development of romiplostim for patients with immune thrombocytopenia.

Authors:  Graham Molineux
Journal:  Ann N Y Acad Sci       Date:  2011-03       Impact factor: 5.691

5.  Monoclonal antibodies isolated without screening by analyzing the variable-gene repertoire of plasma cells.

Authors:  Sai T Reddy; Xin Ge; Aleksandr E Miklos; Randall A Hughes; Seung Hyun Kang; Kam Hon Hoi; Constantine Chrysostomou; Scott P Hunicke-Smith; Brent L Iverson; Philip W Tucker; Andrew D Ellington; George Georgiou
Journal:  Nat Biotechnol       Date:  2010-08-29       Impact factor: 54.908

6.  Challenges associated with the targeted delivery of gelonin to claudin-expressing cancer cells with the use of activatable cell penetrating peptides to enhance potency.

Authors:  Xiaoqin Yuan; Xinjian Lin; Gerald Manorek; Stephen B Howell
Journal:  BMC Cancer       Date:  2011-02-08       Impact factor: 4.430

Review 7.  Pathways and mechanisms of endocytic recycling.

Authors:  Barth D Grant; Julie G Donaldson
Journal:  Nat Rev Mol Cell Biol       Date:  2009-09       Impact factor: 94.444

8.  In vitro and in vivo study of an albumin-binding prodrug of doxorubicin that is cleaved by cathepsin B.

Authors:  Khalid Abu Ajaj; Ralph Graeser; Iduna Fichtner; Felix Kratz
Journal:  Cancer Chemother Pharmacol       Date:  2009-02-20       Impact factor: 3.333

Review 9.  Rilonacept in the treatment of chronic inflammatory disorders.

Authors:  Michael F McDermott
Journal:  Drugs Today (Barc)       Date:  2009-06       Impact factor: 2.245

Review 10.  Denileukin diftitox: a novel immunotoxin.

Authors:  George Manoukian; Fred Hagemeister
Journal:  Expert Opin Biol Ther       Date:  2009-11       Impact factor: 4.388

View more
  368 in total

1.  Expression and display of a novel thermostable esterase from Clostridium thermocellum on the surface of Bacillus subtilis using the CotB anchor protein.

Authors:  Huayou Chen; Tianxi Zhang; Jinru Jia; Ake Vastermark; Rui Tian; Zhong Ni; Zhi Chen; Keping Chen; Shengli Yang
Journal:  J Ind Microbiol Biotechnol       Date:  2015-08-29       Impact factor: 3.346

2.  AcrB-AcrA Fusion Proteins That Act as Multidrug Efflux Transporters.

Authors:  Katsuhiko Hayashi; Ryosuke Nakashima; Keisuke Sakurai; Kimie Kitagawa; Seiji Yamasaki; Kunihiko Nishino; Akihito Yamaguchi
Journal:  J Bacteriol       Date:  2015-11-02       Impact factor: 3.490

3.  Rational design of crystal contact-free space in protein crystals for analyzing spatial distribution of motions within protein molecules.

Authors:  Rei Matsuoka; Atsushi Shimada; Yasuaki Komuro; Yuji Sugita; Daisuke Kohda
Journal:  Protein Sci       Date:  2016-01-13       Impact factor: 6.725

4.  NanoLuc-Based Methods to Measure β-Arrestin2 Recruitment to G Protein-Coupled Receptors.

Authors:  Xiaoyuan Ma; Rob Leurs; Henry F Vischer
Journal:  Methods Mol Biol       Date:  2021

5.  In silico designing, cloning, and heterologous expression of novel chimeric human B lymphocyte CD20 extra loop.

Authors:  Mahdi Fasihi-Ramandi; Jafar Amani; Ali-Hatef Salmanian; Seyed Mohammad Moazzeni; Kazem Ahmadi
Journal:  Tumour Biol       Date:  2016-06-27

6.  Re-engineered RNA-Guided FokI-Nucleases for Improved Genome Editing in Human Cells.

Authors:  Steven Havlicek; Yang Shen; Yunus Alpagu; Michaela B Bruntraeger; Nurdiana B M Zufir; Zhi Yi Phuah; Zhiyan Fu; Norris R Dunn; Lawrence W Stanton
Journal:  Mol Ther       Date:  2017-02-01       Impact factor: 11.454

7.  Construction, Purification, and Characterization of a Homodimeric Granulocyte Colony-Stimulating Factor.

Authors:  Gitana Mickiene; Indre Dalgediene; Zilvinas Dapkunas; Gintautas Zvirblis; Henrikas Pesliakas; Algirdas Kaupinis; Mindaugas Valius; Edita Mistiniene; Milda Pleckaityte
Journal:  Mol Biotechnol       Date:  2017-10       Impact factor: 2.695

8.  Facile Synthesis and Characterization of a Novel Tamavidin-Luciferase Reporter Fusion Protein for Universal Signaling Applications.

Authors:  David B Broyles; Emre Dikici; Sylvia Daunert; Sapna K Deo
Journal:  Adv Biosyst       Date:  2020-02-28

9.  Site-Specific Post-translational Surface Modification of Adeno-Associated Virus Vectors Using Leucine Zippers.

Authors:  Nicole N Thadani; Joanna Yang; Buhle Moyo; Ciaran M Lee; Maria Y Chen; Gang Bao; Junghae Suh
Journal:  ACS Synth Biol       Date:  2020-02-18       Impact factor: 5.110

10.  Rule-based design of synthetic transcription factors in eukaryotes.

Authors:  Oliver Purcell; Jean Peccoud; Timothy K Lu
Journal:  ACS Synth Biol       Date:  2014-01-03       Impact factor: 5.110

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.